218 related articles for article (PubMed ID: 37682775)
21. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
[TBL] [Abstract][Full Text] [Related]
22. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
[TBL] [Abstract][Full Text] [Related]
23. Case-Matched Comparison of Functional and Quality of Life Outcomes of Local Excision and Total Mesorectal Excision Following Chemoradiotherapy for Rectal Cancer.
Brachet S; Meillat H; Chanez B; Ratone JP; Brunelle S; Tyran M; Poizat F; de Chaisemartin C; Lelong B
Dis Colon Rectum; 2022 Dec; 65(12):1464-1474. PubMed ID: 35913830
[TBL] [Abstract][Full Text] [Related]
24. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic Predictors of Residual Tumor After Total Neoadjuvant Therapy: A Post Hoc Analysis From the Organ Preservation in Rectal Adenocarcinoma Trial.
Williams H; Thompson HM; Lin ST; Verheij FS; Omer DM; Qin LX; Garcia-Aguilar J;
Dis Colon Rectum; 2024 Mar; 67(3):369-376. PubMed ID: 38039292
[TBL] [Abstract][Full Text] [Related]
27. Pathological-Features-Modified TNM Staging System Improves Prognostic Accuracy for Rectal Cancer.
Yang Y; Yang Z; Lyu Z; Ouyang K; Wang J; Wu D; Li Y
Dis Colon Rectum; 2024 May; 67(5):645-654. PubMed ID: 38147435
[TBL] [Abstract][Full Text] [Related]
28. Adding Narrow-Band Imaging to Chromoendoscopy for the Evaluation of Tumor Response to Neoadjuvant Therapy in Rectal Cancer.
Ishioka M; Chino A; Ide D; Saito S; Igarashi M; Nagasaki T; Akiyoshi T; Nagayama S; Fukunaga Y; Ueno M; Kawachi H; Yamamoto N; Fujisaki J; Konishi T
Dis Colon Rectum; 2021 Jan; 64(1):53-59. PubMed ID: 32639283
[TBL] [Abstract][Full Text] [Related]
29. 18F-FDG PET/MRI for Rectal Cancer TNM Restaging After Preoperative Chemoradiotherapy: Initial Experience.
Crimì F; Spolverato G; Lacognata C; Garieri M; Cecchin D; Urso ED; Zucchetta P; Pucciarelli S; Pomerri F
Dis Colon Rectum; 2020 Mar; 63(3):310-318. PubMed ID: 31842163
[TBL] [Abstract][Full Text] [Related]
30. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
[TBL] [Abstract][Full Text] [Related]
31. Clinical Implication of Perineural and Lymphovascular Invasion in Rectal Cancer Patients Who Underwent Surgery After Preoperative Chemoradiotherapy.
Kim YI; Kim CW; Kim JH; Kim J; Ro JS; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Dis Colon Rectum; 2022 Nov; 65(11):1325-1334. PubMed ID: 34856592
[TBL] [Abstract][Full Text] [Related]
32. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
[TBL] [Abstract][Full Text] [Related]
33. Optimal Size Criteria for Lateral Lymph Node Dissection After Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Kawai K; Shiratori H; Hata K; Nozawa H; Tanaka T; Nishikawa T; Murono K; Ishihara S
Dis Colon Rectum; 2021 Mar; 64(3):274-283. PubMed ID: 33395141
[TBL] [Abstract][Full Text] [Related]
34. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
[TBL] [Abstract][Full Text] [Related]
35. MRI at Restaging After Neoadjuvant Therapy for Rectal Cancer Overestimates Circumferential Resection Margin Proximity as Determined by Comparison With Whole-Mount Pathology.
Yuval JB; Thompson HM; Firat C; Verheij FS; Widmar M; Wei IH; Pappou E; Smith JJ; Weiser MR; Paty PB; Nash GM; Shia J; Gollub MJ; Garcia-Aguilar J
Dis Colon Rectum; 2022 Apr; 65(4):489-496. PubMed ID: 34803147
[TBL] [Abstract][Full Text] [Related]
36. Local Regrowth and the Risk of Distant Metastases Among Patients Undergoing Watch-and-Wait for Rectal Cancer: What Is the Best Control Group? Multicenter Retrospective Study.
São Julião GP; Fernández LM; Vailati BB; Habr-Gama A; Azevedo JM; Santiago IA; Parés O; Parvaiz A; Vendrely V; Rullier A; Rullier E; Denost Q; Perez RO
Dis Colon Rectum; 2024 Jan; 67(1):73-81. PubMed ID: 37493198
[TBL] [Abstract][Full Text] [Related]
37. The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database.
Fernandez LM; São Julião GP; Renehan AG; Beets GL; Papoila AL; Vailati BB; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Figueiredo NL; Van De Velde CJH; Habr-Gama A; Perez RO;
Dis Colon Rectum; 2023 Jan; 66(1):41-49. PubMed ID: 36515514
[TBL] [Abstract][Full Text] [Related]
38. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
[TBL] [Abstract][Full Text] [Related]
39. Clinical Significance of Preoperative and Postoperative Serum CEA and Carbohydrate Antigen 19-9 Levels in Patients Undergoing Curative Resection of Locally Recurrent Rectal Cancer.
Paku M; Uemura M; Kitakaze M; Miyoshi N; Takahashi H; Mizushima T; Doki Y; Eguchi H
Dis Colon Rectum; 2023 Mar; 66(3):392-400. PubMed ID: 36649161
[TBL] [Abstract][Full Text] [Related]
40. Impact of Total Neoadjuvant Therapy on Postoperative Outcomes After Proctectomy for Rectal Cancer.
Xu Z; Valente MA; Sklow B; Liska D; Gorgun E; Kessler H; Rosen DR; Steele SR
Dis Colon Rectum; 2023 Jul; 66(7):1022-1028. PubMed ID: 36538720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
